Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L MORRIS

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Pharmacotherapy|July 25, 2000
Nalmefene to prevent epidural narcotic side effects in pediatric patients: a pharmacokinetic and safety studyD A Rosen, J L Morris, K R Rosen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 30, 2026
Basal release of 6-cyanodopamine from rabbit isolated aorta and its modulation of vascular reactivityEric Xavier Dos Santos, Kashif Ali, José Britto-Júnior, et al.
Neurology|April 1, 1996
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's diseaseJ T Hutton, W C Koller, J E Ahlskog, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled studyJ T Hutton, L V Metman, T N Chase, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Pharmacotherapy|July 25, 2000
Nalmefene to prevent epidural narcotic side effects in pediatric patients: a pharmacokinetic and safety studyD A Rosen, J L Morris, K R Rosen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 30, 2026
Basal release of 6-cyanodopamine from rabbit isolated aorta and its modulation of vascular reactivityEric Xavier Dos Santos, Kashif Ali, José Britto-Júnior, et al.
Neurology|April 1, 1996
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's diseaseJ T Hutton, W C Koller, J E Ahlskog, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled studyJ T Hutton, L V Metman, T N Chase, et al.
Pageof 15